Form 4: LifeStance Health Director Eric Shuey Receives Equity Compensation Grant
Insider Transaction Report
LifeStance Health Group, Inc. Director Eric Shuey has reported the acquisition of 35,714 restricted stock units (RSUs) as part of a pre-arranged equity compensation plan.
Summary
- Eric Shuey, a Director of LifeStance Health Group, Inc. (LFST), acquired 35,714 shares of common stock on June 11, 2025.
- The acquisition was in the form of Restricted Stock Units (RSUs), with each RSU representing a contingent right to receive one share of the Issuer's common stock.
- The transaction price for these RSUs was $0, indicating they were granted as compensation rather than purchased.
- Following this transaction, Eric Shuey directly beneficially owns 93,982 shares of common stock.
- Additionally, Eric Shuey indirectly beneficially owns 1,110,924 shares, which includes 101,227 shares of restricted stock held by the Eric Shuey Gift Trust.
- The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Sentiment
Score: 6
Explanation: The sentiment is slightly positive. While a routine compensation grant, it signifies continued alignment of a director's interests with the company's performance and is a standard part of executive compensation packages, not indicating any negative underlying issues.
Positives
- The grant of Restricted Stock Units (RSUs) to Director Eric Shuey aligns his interests with those of shareholders, as the value of his compensation is tied to the company's stock performance.
- The transaction was conducted under a Rule 10b5-1(c) plan, indicating a pre-arranged and transparent equity compensation strategy.
Future Outlook
This filing does not contain forward-looking statements or guidance regarding the company's future financial performance or strategic outlook.
Industry Context
This Form 4 filing details a routine equity compensation grant to a director, which is a common practice across various industries to incentivize and retain key personnel by aligning their financial interests with the long-term performance of the company. It does not provide broader industry trends or competitive analysis.
Related Party Transactions
- Shares are held indirectly by the Eric Shuey Gift Trust, which is a related entity to the reporting person, Eric Shuey.
Stakeholder Impact
- Shareholders: The issuance of RSUs may result in minor dilution over time as they vest and convert into common stock, but it also serves to align the director's long-term interests with shareholder value creation.
- Employees/Management: This grant is part of the company's compensation strategy, which aims to attract and retain qualified directors and executives.
Next Steps
- The Restricted Stock Units (RSUs) granted will typically vest over a specified period, at which point they will convert into actual shares of common stock, subject to the terms of the grant agreement.
Key Dates
| Date | Description |
|---|---|
| 06/11/2025 | Date of earliest transaction (acquisition of 35,714 Restricted Stock Units). |
| 06/13/2025 | Date the Form 4 was signed by the Reporting Person's Attorney-in-Fact. |
Keywords
LifeStance Health Group, LFST, Eric Shuey, Director, Restricted Stock Units, RSU, Equity Compensation, Insider Transaction, SEC Form 4, Stock Grant, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.